TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26202881

Group type: EXPERIMENTAL
Intervention: Melatonin supplementation (2 mg for 4 consecutive nights)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Melatonin supplementation
Number of subjects: 12
Study: 23787118

Group type: EXPERIMENTAL
Intervention: Synbiotic yogurt (200 g/day)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control yogurt (200 g/day)
Number of subjects: 65
Study: 21667323

Group type: EXPERIMENTAL
Intervention: Problem-solving education (PSE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 18155491

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (Ca(OH)2) placement after irrigation with 3 mL 17% EDTA and 10 mL 6% sodium hypochlorite (NaOCl)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group irrigated with 10 mL 0.9% saline
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group irrigated with 10 mL 6% sodium hypochlorite (NaOCl)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group irrigated with 3 mL 17% ethylenediaminetetraacetic acid (EDTA) followed by 10 mL 6% NaOCl
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group irrigated with 1 mL 17% EDTA followed by 10 mL 6% NaOCl
Number of subjects: 80
Study: 17063640

Group type: EXPERIMENTAL
Intervention: New ibuprofen preparation (400 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Reference ibuprofen preparation (400 mg)
Number of subjects: 23
Study: 14668079

Group type: EXPERIMENTAL
Intervention: High-dose labetalol (200 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Low-dose labetalol (100 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 10960378

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine containing epinephrine 0.5 microg/kg IV
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 1% lidocaine containing isoproterenol 0.1 microg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline pretreatment followed by the lidocaine‐isoproterenol test dose
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline followed by saline
Number of subjects: 100
Study: 8866274

Group type: EXPERIMENTAL
Intervention: Eccentric isokinetic dynamometry
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Hand-held dynamometry
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Concentric isokinetic dynamometry
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Isometric dynamometry
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Pain scores
Number of subjects: 23
Study: 1497774

Group type: EXPERIMENTAL
Intervention: Objective Structured Clinical Examination (OSCE)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Postexamination questionnaires given to physician examiners
Number of subjects: 240
Study: 6704644

Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Liver Scintigraphy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 35
Study: 31986103

Group type: EXPERIMENTAL
Intervention: Visual biofeedback group (n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (n = 12)
Number of subjects: 24
Study: 30813956

Group type: EXPERIMENTAL
Intervention: PT-RO model
Number of subjects: 156

Group type: COMPARATOR
Intervention: T-RO model
Number of subjects: 156

Group type: COMPARATOR
Intervention: PT-E
Number of subjects: 156
Study: 27613941

Group type: EXPERIMENTAL
Intervention: Culturally specific CBT
Number of subjects: 342

Group type: COMPARATOR
Intervention: Standard CBT
Number of subjects: 342
Study: 27245121

Group type: EXPERIMENTAL
Intervention: Complete revascularization
Number of subjects: 100
Study: 25457355

Group type: EXPERIMENTAL
Intervention: Integrative yoga programme
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group without treatment
Number of subjects: 20
Study: 21892704

Group type: EXPERIMENTAL
Intervention: Letrozole (5 years)
Number of subjects: 746
Study: 20973706

Group type: EXPERIMENTAL
Intervention: Methylphenidate transdermal system (MTS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ADHD symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medication satisfaction, ADHD symptoms, and HRQL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Child HRQL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family HRQL
Number of subjects: 0
Study: 17662509

Group type: EXPERIMENTAL
Intervention: Normal hospital diet plus 400 mL oral nutritional supplements (106 subjects)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Normal hospital diet plus placebo (119 subjects)
Number of subjects: 225
Study: 16325695

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (epirubicin, cyclophosphamide, and thiotepa supported by peripheral-blood progenitors)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Conventional treatment (four cycles of epirubicin and cyclophosphamide followed by three cycles of accelerated cyclophosphamide, methotrexate, and fluorouracil)
Number of subjects: 403
Study: 11809427

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 5 mg
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 516

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 516

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 516
Study: 9642605

Group type: EXPERIMENTAL
Intervention: Antibiotics (amoxicillin and erythromycin)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 8090390

Group type: EXPERIMENTAL
Intervention: Cytobrush and modified Ayers spatula
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Cervex‐Brush
Number of subjects: 352

Group type: COMPARATOR
Intervention: Cotton swab and modified Ayers spatula
Number of subjects: 352
Study: 2518867

Group type: EXPERIMENTAL
Intervention: Cisapride (20 mg for 5 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 793404

Group type: EXPERIMENTAL
Intervention: Topical betamethasone phosphate 0.1% eyedrops, five times daily for two weeks
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo eyedrops, five times daily for two weeks
Number of subjects: 107
Study: 31651246

Group type: EXPERIMENTAL
Intervention: Intrathecal magnesium sulfate (25 mg in 0.5 ml saline)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Intrathecal dexmedetomidine (5 μg in 0.5 ml saline)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (2.5 ml of hyperbaric bupivacaine 0.5% + 0.5 ml normal saline)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 105
Study: 27602993

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 25292351

Group type: EXPERIMENTAL
Intervention: Fluoxetine (acute dose)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 23649281

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment
Number of subjects: 296

Group type: COMPARATOR
Intervention: Control group (non-orthodontic treatment)
Number of subjects: 296
Study: 21602709

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 1905

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1905
Study: 20021921

Group type: EXPERIMENTAL
Intervention: Low-dose amlodipine + diuretics (group A)
Number of subjects: 13542

Group type: EXPERIMENTAL
Intervention: Low-dose amlodipine + telmisartan (group T)
Number of subjects: 13542
Study: 16999566

Group type: EXPERIMENTAL
Intervention: Drug-related problems (DRPs) identified using a hospital adaptation of Dader's method
Number of subjects: 125
Study: 14511080

Group type: EXPERIMENTAL
Intervention: Brief psychodynamic-interpersonal therapy (PIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 10669845

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension (BIS)
Number of subjects: 670

Group type: COMPARATOR
Intervention: Conventional asthma therapy (CAT)
Number of subjects: 670
Study: 9546992

Group type: EXPERIMENTAL
Intervention: Radiation therapy using 192Ir cylindrical seeds (0.3 x 0.05 cm) embedded in a nylon ribbon, delivered via an indwelling coronary catheter.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment (control group).
Number of subjects: 0
Study: 8436632

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine toothpaste (active group)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Chlorhexidine toothpaste with fluoride (active group)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Control group (no chlorhexidine)
Number of subjects: 297
Study: 3524441

Group type: EXPERIMENTAL
Intervention: Intranasal rIFN-alpha A (1.5 X 10(6) IU)
Number of subjects: 587

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 587
Study: 31639080

Group type: EXPERIMENTAL
Intervention: NGO-led training
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Call center utilization
Number of subjects: 777

Group type: COMPARATOR
Intervention: In-shop training from pharmaceutical company representatives
Number of subjects: 777

Group type: COMPARATOR
Intervention: Misoprostol-only regimen provision
Number of subjects: 777
Study: 29578176

Group type: EXPERIMENTAL
Intervention: TPVB plus GA
Number of subjects: 40
Study: 27078115

Group type: EXPERIMENTAL
Intervention: Strength training (12 weeks, 3 times a week)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no strength training)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Strength training (experimental group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Strength gains (1RM test)
Number of subjects: 24
Study: 24231226

Group type: EXPERIMENTAL
Intervention: Risky performance of mobility activities (ADL and IADL)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Declining cognition
Number of subjects: 245
Study: 22521910

Group type: EXPERIMENTAL
Intervention: Edible taste strips containing linoleic acid (75% detection rate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Edible taste strips containing stearic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nasal airflow obstruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: PROP tasters vs. non-tasters
Number of subjects: 0
Study: 19680137

Group type: EXPERIMENTAL
Intervention: ACEIs treatment for 6 weeks
Number of subjects: 509
Study: 17602982

Group type: EXPERIMENTAL
Intervention: Baseline blood urea nitrogen (BUN) >40 mg/dL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline blood urea nitrogen (BUN) quartiles
Number of subjects: 0
Study: 16283864

Group type: EXPERIMENTAL
Intervention: Computer-generated personalized goals (intervention)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 80
Study: 11895281

Group type: EXPERIMENTAL
Intervention: Scaling and root planing with 4 subgingival doses of minocycline microspheres over a 6-month period (RP/M)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional periodontal maintenance (PM) every 3 months
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Scaling and root planing with 4 subgingival doses of minocycline microspheres (RP/M)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional periodontal maintenance (PM)
Number of subjects: 48
Study: 9464738

Group type: EXPERIMENTAL
Intervention: New technique of ureter identification and bladder pillar dissection
Number of subjects: 71

Group type: COMPARATOR
Intervention: Traditional techniques
Number of subjects: 71
Study: 7781496

Group type: EXPERIMENTAL
Intervention: Insulin treated diabetes
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Non-insulin treated diabetes
Number of subjects: 600
Study: 2663744

Group type: EXPERIMENTAL
Intervention: CHO-containing beverage (sucrose, fructose, maltodextrin, or glucose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 73062

Group type: EXPERIMENTAL
Intervention: (+)-cyanidanol-3 (2 g/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31839392

Group type: EXPERIMENTAL
Intervention: 3% hydrogen peroxide
Number of subjects: 140

Group type: COMPARATOR
Intervention: Traditional skin preparation
Number of subjects: 140
Study: 31233896

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure (VRE)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 108
Study: 28099183

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 25913685

Group type: EXPERIMENTAL
Intervention: Nutrition labels on pre-packaged foods
Number of subjects: 0
Study: 23523485

Group type: EXPERIMENTAL
Intervention: Direct Anterior Approach (DAA)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Posterior-Lateral Approach (PA)
Number of subjects: 87
Study: 21186075

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents
Number of subjects: 1749

Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 1749
Study: 19950734

Group type: EXPERIMENTAL
Intervention: Ketamine 100 microg x kg(‐1)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Lidocaine 1 mg x kg(‐1)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Ketamine 50 microg x kg(‐1)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Ketamine 75 microg x kg(‐1)
Number of subjects: 500
Study: 16412856

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/day
Number of subjects: 108
Study: 15253689

Group type: EXPERIMENTAL
Intervention: Biologic agents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional systemic treatments
Number of subjects: 0
Study: 11312479

Group type: EXPERIMENTAL
Intervention: Low-dose milrinone (0.25 microg/kg/min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 20
Study: 9598225

Group type: EXPERIMENTAL
Intervention: Laparoscopic preperitoneal mesh herniorrhaphy
Number of subjects: 49

Group type: COMPARATOR
Intervention: Open preperitoneal mesh herniorrhaphy
Number of subjects: 49
Study: 7943830

Group type: EXPERIMENTAL
Intervention: Ondansetron (0.1 mg/kg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Droperidol (0.02 mg/kg)
Number of subjects: 200
Study: 2979050

Group type: EXPERIMENTAL
Intervention: 1% apraclonidine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 30075919

Group type: EXPERIMENTAL
Intervention: Removable vacuum-formed retainers
Number of subjects: 42

Group type: COMPARATOR
Intervention: Fixed retainers
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both types of retainers
Number of subjects: 42
Study: 26626430

Group type: EXPERIMENTAL
Intervention: IPX066 245-mg LD capsules under fasting conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IPX066 245-mg LD capsules (1 and 2 capsules)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IPX066 245-mg LD capsules sprinkled on applesauce
Number of subjects: 0

Group type: COMPARATOR
Intervention: IPX066 245-mg LD capsules after a high-fat, high-calorie meal
Number of subjects: 0
Study: 25805493

Group type: EXPERIMENTAL
Intervention: Chronic care triage process considering personal care assistance and service methodology
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 22936628

Group type: EXPERIMENTAL
Intervention: One MitraClip device
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Two MitraClip devices
Number of subjects: 233
Study: 20960003

Group type: EXPERIMENTAL
Intervention: 0.4 mg scopolamine (intravenous)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg mecamylamine (max. 15 mg; oral)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 19216273

Group type: EXPERIMENTAL
Intervention: CT scan analysis of maxillary sinus arteries
Number of subjects: 35
Study: 16084689

Group type: EXPERIMENTAL
Intervention: Nocturnal IL-6 secretion in insomniac patients
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Total IL-6 secretion in insomniac patients
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Wake Time in insomniac patients
Number of subjects: 11

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 11
Study: 12848792

Group type: EXPERIMENTAL
Intervention: 360 J shock
Number of subjects: 107

Group type: COMPARATOR
Intervention: 200 J shock
Number of subjects: 107
Study: 10843175

Group type: EXPERIMENTAL
Intervention: Oral estrogen (ethinyl estradiol, conjugated estrogen, and estradiol valerate)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Oral estrogen
Number of subjects: 2

Group type: COMPARATOR
Intervention: Transdermal estrogen
Number of subjects: 2
Study: 9017755

Group type: EXPERIMENTAL
Intervention: Mental Practice
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study: 1798836

Group type: EXPERIMENTAL
Intervention: Alprazolam (1.9 mg daily)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Buspirone (18.7 mg daily)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 6410740

Group type: EXPERIMENTAL
Intervention: Iohexol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Meglumine iothalamate
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sodium meglumine diatrizoate
Number of subjects: 100
Study: 31790890

Group type: EXPERIMENTAL
Intervention: 1.6 g α-lipoic acid (ALA) daily for 6 months
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no ALA treatment)
Number of subjects: 59
Study: 30894317

Group type: EXPERIMENTAL
Intervention: High MI PCI (sonothrombolysis)
Number of subjects: 50

Group type: COMPARATOR
Intervention: PCI only (control)
Number of subjects: 50
Study: 28277390

Group type: EXPERIMENTAL
Intervention: Empowerment program (the ABC empowerment program) for 4 months
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (routine clinical care)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Empowerment program (the ABC empowerment program)
Number of subjects: 78
Study: 26719946

Group type: EXPERIMENTAL
Intervention: Palatal crib (FPC)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Bonded lingual spur (BLS)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 24295024

Group type: EXPERIMENTAL
Intervention: Tailored Cognitive-Behavioral Therapy (TCBT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Standard Cognitive-Behavioral Therapy (SCBT)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Both TCBT and SCBT
Number of subjects: 128
Study: 22089316

Group type: EXPERIMENTAL
Intervention: Paroxetine + Naltrexone
Number of subjects: 88

Group type: COMPARATOR
Intervention: Paroxetine + Placebo
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Desipramine + Naltrexone
Number of subjects: 88

Group type: COMPARATOR
Intervention: Desipramine + Placebo
Number of subjects: 88
Study: 21143897

Group type: EXPERIMENTAL
Intervention: Longer hormonal treatment
Number of subjects: 3424
Study: 17662554

Group type: EXPERIMENTAL
Intervention: Mouthwash oral-throat rinses
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Water oral-throat rinses
Number of subjects: 561

Group type: COMPARATOR
Intervention: Pharyngeal swabs
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Overall prevalence of pharyngeal gonorrhea
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Overall prevalence of pharyngeal chlamydia
Number of subjects: 561
Study: 15812256

Group type: EXPERIMENTAL
Intervention: Valsartan 160 mg od + Hydrochlorothiazide 12.5 mg
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Valsartan 160 mg od + Hydrochlorothiazide 25 mg
Number of subjects: 474

Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 474
Study: 16629842

Group type: EXPERIMENTAL
Intervention: Open‐rota system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard scheduling)
Number of subjects: 0
Study: 9892402

Group type: EXPERIMENTAL
Intervention: Intermittent treatment with zidovudine (AZT) plus zalcitabine (ddC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Continuous treatment with zidovudine (AZT) plus zalcitabine (ddC)
Number of subjects: 49
Study: 8897035

Group type: EXPERIMENTAL
Intervention: Concentric isokinetic torque (CIT) testing at velocities of 30, 60, 120, and 180 degrees.s‐1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Angular delay from onset of concentric activation to peak torque at 120 and 180 degrees.s‐1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Maximal dorsiflexion (DF) angle and change in passive extensibility (PE) angle
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Standardized peak torques and mean torques
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Angular delay at 120 and 180 degrees.s‐1
Number of subjects: 20
Study: 1676973

Group type: EXPERIMENTAL
Intervention: CV 205-502
Number of subjects: 45

Group type: COMPARATOR
Intervention: Bromocriptine
Number of subjects: 45
Study: 6870216

Group type: EXPERIMENTAL
Intervention: Intranasal enviroxime, given 6 times a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal enviroxime (in volunteers without symptoms at the start of medication)
Number of subjects: 0
Study: 31399115

Group type: EXPERIMENTAL
Intervention: Cyber Knife (CK)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sliding Window (SW)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Volumetric Modulated Arc Therapy (VMAT)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Helical Tomotherapy (HT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Intensity-Modulated Radiation Therapy (IMRT) techniques
Number of subjects: 27